165 related articles for article (PubMed ID: 24276465)
1. MEN1 gene mutation and reduced expression are associated with poor prognosis in pulmonary carcinoids.
Swarts DR; Scarpa A; Corbo V; Van Criekinge W; van Engeland M; Gatti G; Henfling ME; Papotti M; Perren A; Ramaekers FC; Speel EJ; Volante M
J Clin Endocrinol Metab; 2014 Feb; 99(2):E374-8. PubMed ID: 24276465
[TBL] [Abstract][Full Text] [Related]
2. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity on chromosome arm 11q in lung carcinoids.
Petzmann S; Ullmann R; Klemen H; Renner H; Popper HH
Hum Pathol; 2001 Mar; 32(3):333-8. PubMed ID: 11274644
[TBL] [Abstract][Full Text] [Related]
4. CD44 and OTP are strong prognostic markers for pulmonary carcinoids.
Swarts DR; Henfling ME; Van Neste L; van Suylen RJ; Dingemans AM; Dinjens WN; Haesevoets A; Rudelius M; Thunnissen E; Volante M; Van Criekinge W; van Engeland M; Ramaekers FC; Speel EJ
Clin Cancer Res; 2013 Apr; 19(8):2197-207. PubMed ID: 23444222
[TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome.
D'Adda T; Keller G; Bordi C; Höfler H
Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509
[TBL] [Abstract][Full Text] [Related]
6. MEN1 gene mutation analysis of high-grade neuroendocrine lung carcinoma.
Debelenko LV; Swalwell JI; Kelley MJ; Brambilla E; Manickam P; Baibakov G; Agarwal SK; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Travis WD; Emmert-Buck MR
Genes Chromosomes Cancer; 2000 May; 28(1):58-65. PubMed ID: 10738303
[TBL] [Abstract][Full Text] [Related]
7. Identification of MEN1 gene mutations in sporadic carcinoid tumors of the lung.
Debelenko LV; Brambilla E; Agarwal SK; Swalwell JI; Kester MB; Lubensky IA; Zhuang Z; Guru SC; Manickam P; Olufemi SE; Chandrasekharappa SC; Crabtree JS; Kim YS; Heppner C; Burns AL; Spiegel AM; Marx SJ; Liotta LA; Collins FS; Travis WD; Emmert-Buck MR
Hum Mol Genet; 1997 Dec; 6(13):2285-90. PubMed ID: 9361035
[TBL] [Abstract][Full Text] [Related]
8. Gene Expression Profiling of Lung Atypical Carcinoids and Large Cell Neuroendocrine Carcinomas Identifies Three Transcriptomic Subtypes with Specific Genomic Alterations.
Simbolo M; Barbi S; Fassan M; Mafficini A; Ali G; Vicentini C; Sperandio N; Corbo V; Rusev B; Mastracci L; Grillo F; Pilotto S; Pelosi G; Pelliccioni S; Lawlor RT; Tortora G; Fontanini G; Volante M; Scarpa A; Bria E
J Thorac Oncol; 2019 Sep; 14(9):1651-1661. PubMed ID: 31085341
[TBL] [Abstract][Full Text] [Related]
9. Expression of developing neural transcription factors in lung carcinoid tumors.
Endo T; Yazawa T; Shishido-Hara Y; Fujiwara M; Shimoyamada H; Ishii J; Sato H; Tachibana K; Takei H; Kondo H; Goya T; Endo S; Kamma H
Pathol Int; 2014 Aug; 64(8):365-74. PubMed ID: 25143124
[TBL] [Abstract][Full Text] [Related]
10. Gene product immunophenotyping of neuroendocrine lung tumors. No linking evidence between carcinoids and small-cell lung carcinomas suggested by multivariate statistical analysis.
Sampietro G; Tomasic G; Collini P; Biganzoli E; Boracchi P; Bidoli P; Pilotti S
Appl Immunohistochem Mol Morphol; 2000 Mar; 8(1):49-56. PubMed ID: 10937049
[TBL] [Abstract][Full Text] [Related]
11. Mutations and allelic deletions of the MEN1 gene are associated with a subset of sporadic endocrine pancreatic and neuroendocrine tumors and not restricted to foregut neoplasms.
Görtz B; Roth J; Krähenmann A; de Krijger RR; Muletta-Feurer S; Rütimann K; Saremaslani P; Speel EJ; Heitz PU; Komminoth P
Am J Pathol; 1999 Feb; 154(2):429-36. PubMed ID: 10027401
[TBL] [Abstract][Full Text] [Related]
12. Specific Genomic Alterations in High-Grade Pulmonary Neuroendocrine Tumours with Carcinoid Morphology.
Cros J; Théou-Anton N; Gounant V; Nicolle R; Reyes C; Humez S; Hescot S; Thomas de Montpréville V; Guyétant S; Scoazec JY; Guyard A; de Mestier L; Brosseau S; Mordant P; Castier Y; Gentien D; Ruszniewski P; Zalcman G; Couvelard A; Cazes A
Neuroendocrinology; 2021; 111(1-2):158-169. PubMed ID: 32015233
[TBL] [Abstract][Full Text] [Related]
13. Genetic changes in the spectrum of neuroendocrine lung tumors.
Onuki N; Wistuba II; Travis WD; Virmani AK; Yashima K; Brambilla E; Hasleton P; Gazdar AF
Cancer; 1999 Feb; 85(3):600-7. PubMed ID: 10091733
[TBL] [Abstract][Full Text] [Related]
14. A novel germline mutation, 1793delG, of the MEN1 gene underlying multiple endocrine neoplasia type 1.
Snabboon T; Plengpanich W; Siriwong S; Wisedopas N; Suwanwalaikorn S; Khovidhunkit W; Shotelersuk V
Jpn J Clin Oncol; 2005 May; 35(5):280-2. PubMed ID: 15894711
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability and loss of heterozygosity at the MEN1 locus in lung carcinoid tumors: a novel approach using real-time PCR with melting curve analysis in histopathologic material.
Vageli D; Daniil Z; Dahabreh J; Karagianni E; Liloglou T; Koukoulis G; Gourgoulianis K
Oncol Rep; 2006 Mar; 15(3):557-64. PubMed ID: 16465412
[TBL] [Abstract][Full Text] [Related]
16. An exploration of pathways involved in lung carcinoid progression using gene expression profiling.
Swarts DR; Van Neste L; Henfling ME; Eijkenboom I; Eijk PP; van Velthuysen ML; Vink A; Volante M; Ylstra B; Van Criekinge W; van Engeland M; Ramaekers FC; Speel EJ
Carcinogenesis; 2013 Dec; 34(12):2726-37. PubMed ID: 23929435
[TBL] [Abstract][Full Text] [Related]
17. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the expression of p53, KLF4, and p21 in neuroendocrine lung tumors.
Naranjo Gómez JM; Bernal JF; Arranz PG; Fernández SL; Roman JJ
Arch Pathol Lab Med; 2014 Jul; 138(7):936-42. PubMed ID: 24978920
[TBL] [Abstract][Full Text] [Related]
19. 11q13 allelic imbalance discriminates pulmonary carcinoids from tumorlets. A microdissection-based genotyping approach useful in clinical practice.
Finkelstein SD; Hasegawa T; Colby T; Yousem SA
Am J Pathol; 1999 Aug; 155(2):633-40. PubMed ID: 10433956
[TBL] [Abstract][Full Text] [Related]
20. New Insights into the Molecular Characteristics of Pulmonary Carcinoids and Large Cell Neuroendocrine Carcinomas, and the Impact on Their Clinical Management.
Derks JL; Leblay N; Lantuejoul S; Dingemans AC; Speel EM; Fernandez-Cuesta L
J Thorac Oncol; 2018 Jun; 13(6):752-766. PubMed ID: 29454048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
